Lamy Patrick 4
4 · Akero Therapeutics, Inc. · Filed Jul 3, 2025
Insider Transaction Report
Form 4
Lamy Patrick
Senior VP, Commercial Strategy
Transactions
- Sale
Common Stock
2025-07-01$52.88/sh−2,000$105,760→ 29,891 total
Footnotes (1)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 6, 2025, previously adopted by the Reporting Person.